Primary central nervous system lymphoma: Age and performance status are more important than treatment modality

International Journal of Radiation Oncology Biology Physics

Volumn 41, Issue 3, 1998, Pages 615-620

  Corry, June ^a   Smith, Jennifer G ^a   Wirth, Andrew ^a   Quong, George ^b   Liew, Kuen Hoe ^a  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

^b AUSTIN HEALTH   (Australia)

Author keywords

Chemotherapy; Primary central nervous system lymphoma; Radiotherapy

Indexed keywords

AGE; ARTICLE; BRAIN LYMPHOMA; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TREATMENT FAILURE;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; BRAIN NEOPLASMS; CAUSE OF DEATH; CENTRAL NERVOUS SYSTEM NEOPLASMS; CHILD; FEMALE; HUMANS; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; PROGNOSIS; RECURRENCE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 0031749549     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(97)00571-3     Document Type: Article

References (22)

1. Balmaceda C., Gaynor J.J., Sun M., Gluck J.T., DeAngelis L.M. Leptomeningeal tumor in primary central nervous system lymphoma Recognition, significance, and implications . Ann. Neurol. 38:1995;202-209.
2. Berry M.P., Simpson W.J. Radiation therapy in the management of primary malignant lymphoma of the brain. Int. J. Radiat. Oncol. Biol. Phys. 7:1981;55-59.
3. Brada M., Dearnaley D., Horwich A., Bloom H.J.G. Management of primary cerebral lymphoma with initial chemotherapy preliminary results and comparison with patients treated with radiotherapy alone . Int. J. Radiat. Oncol. Biol. Phys. 18:1990;787-792.
4. Cher L., Glass J., Harsh G.R., Hochberg F.H. Therapy of primary CNS lymphoma with methotrexate-based chemotherapy and deferred radiotherapy Preliminary results . Neurology. 46:1996;1757-1759.
5. DeAngelis L.M., Yahalom J., Heinemann M.H., Cirrincione C., Thaler H.T., Krol G. Primary CNS lymphoma Combined treatment with chemotherapy and radiotherapy . Neurology. 40:1990;80-86.
6. DeAngelis L.M., Yahalom J., Thaler H.T., Kher U. Combined modality therapy for primary CNS lymphoma. J. Clin. Oncol. 10:1992;635-643.
7. Dixon W.J., Brown M.B., Engelman L., Jennrich R.I. BMDP statistical software. 1988;1993 University of California Press, Berkeley, CA.
8. Gabbai A.A., Hochberg F.H., Linggood R.M., Bashir R., Hotleman K. High-dose methotrexate for non-AIDS primary central nervous system lymphoma Report of 13 cases . J. Neurosurg. 70:1989;190-194.
9. Krogh-Jensen M., d'Amore F., Jensen M.K., Christensen B.E., Thorling K., Pedersen M., Johansen P., Boesen A.M., Andersen E. Incidence, clinicopathological features and outcome of primary central nervous system lymphomas Population-based data from a Danish lymphoma registry . Ann. Oncol. 5:1994;349-354.
10. Letendre L., Banks P.M., Reese D.F., Miller R.H., Scanlon P.W., Kiely J.M. Primary lymphoma of the central nervous system. Cancer. 49:1982;939-943.
11. Littman P., Wang C.C. Reticulum cell sarcoma of the brain. Cancer. 35:1975;1412-1420.
12. Loeffler J.S., Ervin T.J., Mauch P., Skarin A., Weinstein H.J., Canellos G., Cassady J.R. Primary lymphomas of the central nervous system Patterns of failure and factors that influence survival . J. Clin. Oncol. 3:1985;490-494.
13. Nelson D.F., Martz K.L., Bonner H., Nelson J.S., Newall J., Kerman H.D., Thomson J.W., Murray K.J. Non-Hodgkin's lymphoma of the brain Can high dose, large volume radiation therapy improve survival? Report on a prospective trial by the Radiation Therapy Oncology Group (RTOG): RTOG 8315 . Int. J. Radiat. Oncol. Biol. Phys. 23:1992;9-17.
14. Neuwelt E.A., Goldman D.L., Dahlborg S.A., Crossen J., Ramsey F., Roman-Goldstein S., Braziel R., Dana B. Primary CNS lymphoma treated with osmotic blood-brain barrier disruption prolonged survival and preservation of cognitive function . J. Clin. Oncol. 9:1991;1580-1590.
15. O'Neill B.P., O'Fallon J.R., Earle J.D., Colgan J.P., Brown L.D., Krigel R.L. Primary central nervous system non-Hodgkin's lymphoma Survival advantages with combined initial therapy? Int. J. Radiat. Oncol. Biol. Phys. 33:1995;663-673.
16. Pollack I.F., Lunsford L.D., Flickinger J.C., Dameshek H.L. Prognostic factors in the diagnosis and treatment of primary central nervous system lymphoma. Cancer. 63:1989;939-947.
17. Rampen F.H.J., van Andel J.G., Sizoo W., van Unnik J.A.M. Radiation therapy in primary non-Hodgkin's lymphomas of the CNS. Eur. J. Cancer. 16:1980;177-184.
18. Sagerman R.H., Collier C.H., King G.A. Radiation therapy of microgliomas. Radiology. 149:1983;567-570.
19. Schultz C., Scott C., Sherman W., Donahue B., Fields J., Murray K., Fisher B., Abrams R., Meis-Kindblom J. Preirradiation chemotherapy with cyclophosphamide, doxorubicin, vincristine, and dexamethasone for primary CNS lymphomas Initial report of Radiation Therapy Oncology Group protocol 88-06 . J. Clin. Oncol. 14:1996;556-564.
20. Shibamoto Y., Tsutsui K., Dodo Y., Yamabe H., Shima N., Abe M. Improved survival rate in primary intracranial lymphoma treated by high-dose radiation and systemic vincristine-doxorubicin-cyclophosphamide-prednisolone chemotherapy. Cancer. 65:1990;1907-1912.
21. Socié G., Piprot-Chauffat C., Schlienger M., Legars D., Thurel C., Mikol J., Ifran N., Brière J., Pene F., Gindrey-Vie B., Marin J.L., Desablens B., Laugier A. Primary lymphoma of the central nervous system An unresolved therapeutic problem . Cancer. 65:1990;322-326.
22. WHO handbook for reporting results of cancer treatment. 1979;World Health Organization, Geneva.